| Previous close | 435.15 |
| Open | 437.60 |
| Bid | 435.00 x 0 |
| Ask | 435.15 x 0 |
| Day's range | 434.15 - 437.90 |
| 52-week range | 331.70 - 456.30 |
| Volume | 3,400,322 |
| Avg. volume | 2,198,416 |
| Market cap | 1.012T |
| Beta (5Y monthly) | 0.33 |
| PE ratio (TTM) | 24.77 |
| EPS (TTM) | 17.56 |
| Earnings date | N/A |
| Forward dividend & yield | 8.60 (1.98%) |
| Ex-dividend date | 14 Aug 2020 |
| 1y target est | 326.96 |
- Zacks
Top Analyst Reports for JPMorgan, PayPal & Novo Nordisk
Top Analyst Reports for JPMorgan, PayPal & Novo Nordisk
- Zacks
SNY vs. NVO: Which Stock Should Value Investors Buy Now?
SNY vs. NVO: Which Stock Is the Better Value Option?
- Motley Fool
Why Altimmune Stock Tanked Today
What happened Shares of Altimmune (NASDAQ: ALT) were down by 15% as of 3:27 p.m. EDT on Wednesday. The biotech announced before the market opened that it would present preclinical data for ALT-801 in treating nonalcoholic steatohepatitis (NASH) at the European Association for the Study of the Liver annual meeting on Aug.
© 2020 Verizon Media. All rights reserved.
